Skye Bioscience Completes Drug Production for Phase 1 Clinical Study
SAN DIEGO-- Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company ...
SAN DIEGO-- Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company ...
TAMPA, Fla., Sept. 20, 2022 Mr. Hemp Flower ©, the manufacturer and distributor ...
OAKLAND, Calif., Sept. 20, 2022 Kiva Confections announced today the ...
LONDON, Sept. 19, 2022 With the UK medical cannabis market ...
LAS VEGAS - MJ Unpacked, the first national event created ...
SMITHS FALLS, ON, Sept. 19, 2022. Canopy Growth Corporation announced ...
WAKEFIELD, Mass., Sept. 19, 2022 Curaleaf Holdings, Inc. a provider ...
NEW YORK–Despite the current downturn in cannabis in 2022, the ...
MONTREAL–(NORML) Despite the federal government having legalized patients’ access to ...
FARGO, N.D–(NORML) States that license adult-use marijuana sales may experience ...